Home LiteratureArticle Details
PMID: 1635550 Published · ppublish English Journal Article

Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.

Molecular pharmacology ·Vol. 42 ·No. 1 ·1992-07-00 ·Pages 123-33

Jacobson KA, Stiles GL, Ji XD

Abstract

The ligand recognition site of A2a-adenosine receptors in rabbit striatal membranes was probed using non-site-directed labeling reagents and specific affinity labels. Exposure of membranes to diethylpyrocarbonate at a concentration of 2.5 mM, followed by washing, was found to inhibit the binding of [3H]CGS 21680 and [3H]xanthine amine congener to A2a receptors, by 86 and 30%, respectively. Protection from diethylpyrocarbonate inactivation by an adenosine receptor agonist, 5'-N-ethylcarboxamidoadenosine, and an antagonist, theophylline, suggested the presence of two histidyl residues on the receptor, one associated with agonist binding and the other with antagonist binding. Binding of [3H]CGS 21680 or [3H]xanthine amine congener was partially restored after incubation with 250 mM hydroxylamine, further supporting histidine as the modification site. Preincubation with disulfide-reactive reagents, dithiothreitol or sodium dithionite, at greater than 5 mM inhibited radioligand binding, indicating the presence of essential disulfide bridges in A2a receptors, whereas the concentration of mercaptoethanol required to inhibit binding was greater than 50 mM. A number of isothiocyanate-bearing affinity labels derived from the A2a-selective agonist 2-[(2-aminoethylamino) carbonylethylphenylethylamino]-5'-N- ethylcarboxamidoadenosine (APEC) were synthesized and found to inhibit A2a receptor binding in rabbit and bovine striatal membranes. Binding to rabbit A1 receptors was not inhibited. Preincubation with the affinity label 4-isothiocyanatophenylaminothiocarbonyl-APEC (100 nM) diminished the Bmax for [3H]CGS 21680 binding by 71%, and the Kd was unaffected, suggesting a direct modification of the ligand binding site. Reversal of 4-isothiocyanatophenylaminothiocarbonyl-APEC inhibition of [3H]CGS 21680 binding with hydroxylamine suggested that the site of modification by the isothiocyanate is a cysteine residue. A bromoacetyl derivative of APEC was ineffective as an affinity label at submicromolar concentrations.

MeSH Terms
Adenosine/analogs & derivatives,metabolism,pharmacology Adenosine-5'-(N-ethylcarboxamide) Affinity Labels Amino Acid Sequence Animals Corpus Striatum/drug effects,metabolism Diethyl Pyrocarbonate/pharmacology Drug Antagonism Hydroxylamine Hydroxylamines/pharmacology Molecular Sequence Data Phenethylamines/metabolism Purinergic Antagonists Rabbits Radioligand Assay Receptors, Purinergic/chemistry,drug effects,metabolism Theophylline/pharmacology Xanthines/metabolism
Chemicals
Affinity Labels Hydroxylamines Phenethylamines Purinergic Antagonists Receptors, Purinergic Xanthines 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine Hydroxylamine Adenosine-5'-(N-ethylcarboxamide) 8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine Theophylline Adenosine Diethyl Pyrocarbonate
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Jacobson K A
Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
Stiles G L
Ji X D
References (24)
24 references, click to expand
  1. Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonism.
    J Pharmacol Exp Ther. 1991 Oct;259(1):286-94 PMID: 1920121
  2. Chemical modification of adenosine A1 receptors. Implications for the interaction with R-PIA, DPCPX and amiloride.
    Biochem Pharmacol. 1990 Aug 15;40(4):835-42 PMID: 2143656
  3. Modification of histidyl residues in proteins by diethylpyrocarbonate.
    Methods Enzymol. 1977;47:431-42 PMID: 22021
  4. A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.
    Mol Pharmacol. 1992 Feb;41(2):352-9 PMID: 1311411
  5. Adenosine A1 and A2 receptors: structure--function relationships.
    Med Res Rev. 1992 Sep;12(5):423-71 PMID: 1513184
  6. [(3)H]XAC (xanthine amine congener) is a radioligand for A(2)-adenosine receptors in rabbit striatum.
    Neurochem Int. 1991;18(2):207-13 PMID: 20504695
  7. High affinity acylating antagonists for the A1 adenosine receptor: identification of binding subunit.
    Mol Pharmacol. 1988 Dec;34(6):724-8 PMID: 3200248
  8. Chemical modification of A1 adenosine receptors in rat brain membranes. Evidence for histidine in different domains of the ligand binding site.
    J Biol Chem. 1988 Nov 25;263(33):17522-6 PMID: 3182861
  9. Probing the adenosine receptor with adenosine and xanthine biotin conjugates.
    FEBS Lett. 1985 May 6;184(1):30-5 PMID: 2985445
  10. Separation of solubilized A2 adenosine receptors of human platelets from non-receptor [3H]NECA binding sites by gel filtration.
    Naunyn Schmiedebergs Arch Pharmacol. 1988 Jan;337(1):64-8 PMID: 2835689
  11. Identification of the A2 adenosine receptor binding subunit by photoaffinity crosslinking.
    Proc Natl Acad Sci U S A. 1989 Sep;86(17):6572-6 PMID: 2771944
  12. Electrophilic derivatives of purines as irreversible inhibitors of A1 adenosine receptors.
    J Med Chem. 1989 May;32(5):1043-51 PMID: 2709373
  13. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
    J Pharmacol Exp Ther. 1989 Dec;251(3):888-93 PMID: 2600819
  14. Agonist derived molecular probes for A2 adenosine receptors.
    J Mol Recognit. 1989 Dec;2(4):170-8 PMID: 2561548
  15. Selective amplification and cloning of four new members of the G protein-coupled receptor family.
    Science. 1989 May 5;244(4904):569-72 PMID: 2541503
  16. Cardiovascular purinoceptors.
    Physiol Rev. 1990 Jul;70(3):761-845 PMID: 2194223
  17. Cloning and expression of an A1 adenosine receptor from rat brain.
    Mol Pharmacol. 1991 Jul;40(1):1-7 PMID: 1857334
  18. Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors.
    Bioconjug Chem. 1991 Mar-Apr;2(2):77-88 PMID: 1868116
  19. The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis.
    Mol Pharmacol. 1991 Feb;39(2):130-5 PMID: 1899902
  20. Distinct pathways of desensitization of A1- and A2-adenosine receptors in DDT1 MF-2 cells.
    Mol Pharmacol. 1991 Nov;40(5):639-47 PMID: 1944235
  21. Inhibition of muscarinic cholinergic receptors by disulfide reducing agents and arsenicals. Differential effect on locust and rat.
    Biochem Pharmacol. 1991 Mar 1;41(5):735-42 PMID: 1998528
  22. Evidence for the participation of histidine residues located in the 56 kDa C-terminal polypeptide domain of ADP-ribosyl transferase in its catalytic activity.
    FEBS Lett. 1990 Oct 29;273(1-2):6-10 PMID: 2121544
  23. RDC8 codes for an adenosine A2 receptor with physiological constitutive activity.
    Biochem Biophys Res Commun. 1990 Dec 31;173(3):1169-78 PMID: 2125216
  24. The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively.
    J Clin Invest. 1990 Apr;85(4):1150-7 PMID: 2156895
Article Info
Journal
Molecular pharmacology
Abbr.
Mol Pharmacol
ISSN
0026-895X
Published
1992-07-00
Pages
123-33
Language
English
Region
United States
NLM ID
0035623
PMCID
PMC3429947
Subset
IM
Grants
Intramural NIH HHS · Z01 DK031115-24 · United States
Intramural NIH HHS · Z99 DK999999 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com